Jonathan M. Kurie

7.7k total citations
101 papers, 5.3k citations indexed

About

Jonathan M. Kurie is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Jonathan M. Kurie has authored 101 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 32 papers in Oncology and 29 papers in Genetics. Recurrent topics in Jonathan M. Kurie's work include Retinoids in leukemia and cellular processes (30 papers), Estrogen and related hormone effects (23 papers) and PI3K/AKT/mTOR signaling in cancer (12 papers). Jonathan M. Kurie is often cited by papers focused on Retinoids in leukemia and cellular processes (30 papers), Estrogen and related hormone effects (23 papers) and PI3K/AKT/mTOR signaling in cancer (12 papers). Jonathan M. Kurie collaborates with scholars based in United States, France and South Korea. Jonathan M. Kurie's co-authors include Waun Ki Hong, Ho‐Young Lee, Ignacio I. Wistuba, Fadlo R. Khuri, Dianna D. Cody, Marie Wislez, Roger E. Price, J. Jack Lee, Don L. Gibbons and Chad J. Creighton and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Jonathan M. Kurie

101 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan M. Kurie United States 45 3.2k 1.9k 1.2k 998 724 101 5.3k
Domenico Delia Italy 43 4.2k 1.3× 2.5k 1.3× 462 0.4× 1.2k 1.2× 565 0.8× 125 6.9k
Lu‐Zhe Sun United States 40 2.9k 0.9× 1.7k 0.9× 487 0.4× 892 0.9× 435 0.6× 125 4.5k
Daniel Medina United States 51 3.9k 1.2× 4.3k 2.2× 559 0.5× 1.7k 1.7× 1.3k 1.8× 184 7.7k
Johan Botling Sweden 39 2.8k 0.9× 1.6k 0.8× 1.1k 0.9× 1.2k 1.2× 289 0.4× 117 5.3k
Elvira Pelosi Italy 47 4.5k 1.4× 1.5k 0.8× 707 0.6× 2.3k 2.3× 417 0.6× 170 7.9k
Pedram Argani United States 34 3.4k 1.0× 1.9k 1.0× 553 0.5× 1.5k 1.5× 544 0.8× 54 5.1k
Chuan‐Yuan Li United States 40 3.6k 1.1× 1.6k 0.9× 541 0.5× 1.4k 1.4× 450 0.6× 115 6.0k
Maréne Landström Sweden 32 3.2k 1.0× 1.3k 0.7× 553 0.5× 1.0k 1.0× 437 0.6× 81 4.7k
Félix Bonilla Spain 45 4.0k 1.2× 2.0k 1.1× 612 0.5× 2.2k 2.2× 594 0.8× 100 6.3k
Giulia Taraboletti Italy 47 4.0k 1.2× 2.1k 1.1× 506 0.4× 2.2k 2.2× 262 0.4× 112 7.1k

Countries citing papers authored by Jonathan M. Kurie

Since Specialization
Citations

This map shows the geographic impact of Jonathan M. Kurie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan M. Kurie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan M. Kurie more than expected).

Fields of papers citing papers by Jonathan M. Kurie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan M. Kurie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan M. Kurie. The network helps show where Jonathan M. Kurie may publish in the future.

Co-authorship network of co-authors of Jonathan M. Kurie

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan M. Kurie. A scholar is included among the top collaborators of Jonathan M. Kurie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan M. Kurie. Jonathan M. Kurie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Sieun, Jihye Park, Eun Ju Kim, et al.. (2025). Hyaluronan network remodeling by ZEB1 and ITIH2 enhances the motility and invasiveness of cancer cells. Journal of Clinical Investigation. 135(11). 1 indexed citations
2.
Tan, Xiaochao, Guan-Yu Xiao, Lei Shi, et al.. (2023). EMT-activated secretory and endocytic vesicular trafficking programs underlie a vulnerability to PI4K2A antagonism in lung cancer. Journal of Clinical Investigation. 133(7). 15 indexed citations
3.
Tan, Xiaochao, Priyam Banerjee, Lei Shi, et al.. (2021). p53 loss activates prometastatic secretory vesicle biogenesis in the Golgi. Science Advances. 7(25). 20 indexed citations
4.
Tan, Xiaochao, Priyam Banerjee, Xin Liu, et al.. (2021). Transcriptional control of a collagen deposition and adhesion process that promotes lung adenocarcinoma growth and metastasis. JCI Insight. 7(1). 17 indexed citations
5.
Tan, Xiaochao, Lei Shi, Priyam Banerjee, et al.. (2020). A protumorigenic secretory pathway activated by p53 deficiency in lung adenocarcinoma. Journal of Clinical Investigation. 131(1). 32 indexed citations
6.
Yang, Yanan, Young‐Ho Ahn, Yulong Chen, et al.. (2014). ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism. Journal of Clinical Investigation. 124(6). 2696–2708. 101 indexed citations
7.
Ma, Tian, Fabrizio Galimberti, Cherie P. Erkmen, et al.. (2013). Comparing Histone Deacetylase Inhibitor Responses in Genetically Engineered Mouse Lung Cancer Models and a Window of Opportunity Trial in Patients with Lung Cancer. Molecular Cancer Therapeutics. 12(8). 1545–1555. 20 indexed citations
8.
Schliekelman, Mark J., Don L. Gibbons, Vítor M. Faça, et al.. (2011). Targets of the Tumor Suppressor miR-200 in Regulation of the Epithelial–Mesenchymal Transition in Cancer. Cancer Research. 71(24). 7670–7682. 110 indexed citations
9.
Dragnev, Konstantin H., Tian Ma, Fabrizio Galimberti, et al.. (2011). Bexarotene Plus Erlotinib Suppress Lung Carcinogenesis Independent of KRAS Mutations in Two Clinical Trials and Transgenic Models. Cancer Prevention Research. 4(6). 818–828. 40 indexed citations
10.
Iwanaga, Kentaro, Yanan Yang, Maria Gabriela Raso, et al.. (2008). Pten Inactivation Accelerates Oncogenic K-ras –Initiated Tumorigenesis in a Mouse Model of Lung Cancer. Cancer Research. 68(4). 1119–1127. 92 indexed citations
11.
Zhang, Jie, Kentaro Iwanaga, Kuicheon Choi, et al.. (2008). Intratumoral Epiregulin Is a Marker of Advanced Disease in Non–Small Cell Lung Cancer Patients and Confers Invasive Properties on EGFR -Mutant Cells. Cancer Prevention Research. 1(3). 201–207. 59 indexed citations
12.
Sun, Hongxia, Wen-Cheng Chung, Zhenlin Ju, et al.. (2008). Cyclic AMP-Responsive Element Binding Protein– and Nuclear Factor-κB–Regulated CXC Chemokine Gene Expression in Lung Carcinogenesis. Cancer Prevention Research. 1(5). 316–328. 57 indexed citations
13.
Li, Zhong, Jonathon D. Roybal, Raghothama Chaerkady, et al.. (2008). Identification of Secreted Proteins that Mediate Cell-Cell Interactions in an In vitro Model of the Lung Cancer Microenvironment. Cancer Research. 68(17). 7237–7245. 68 indexed citations
14.
Wislez, Marie, Nobukazu Fujimoto, Julie Izzo, et al.. (2006). High Expression of Ligands for Chemokine Receptor CXCR2 in Alveolar Epithelial Neoplasia Induced by Oncogenic Kras. Cancer Research. 66(8). 4198–4207. 130 indexed citations
15.
Xia, Dianren, Young‐Ho Ahn, Gautam Sethi, et al.. (2006). Mitogen-activated Protein Kinase Kinase-4 Promotes Cell Survival by Decreasing PTEN Expression through an NFκB-dependent Pathway. Journal of Biological Chemistry. 282(6). 3507–3519. 84 indexed citations
16.
Wislez, Marie, Loreto Spencer, Julie Izzo, et al.. (2005). Inhibition of Mammalian Target of Rapamycin Reverses Alveolar Epithelial Neoplasia Induced by Oncogenic K-ras. Cancer Research. 65(8). 3226–3235. 128 indexed citations
17.
Juroske, Denise M., Shailaja Kalyankrishna, Dianna D. Cody, et al.. (2005). c-Jun N-Terminal Kinase Contributes to Aberrant Retinoid Signaling in Lung Cancer Cells by Phosphorylating and Inducing Proteasomal Degradation of Retinoic Acid Receptor α. Molecular and Cellular Biology. 25(3). 1054–1069. 54 indexed citations
18.
Zhang, Li, J. Jack Lee, Hongli Tang, et al.. (2005). Impact of smoking cessation on global gene expression in bronchial epithelium of chronic smokers. Cancer Research. 65. 207–207. 1 indexed citations
19.
Tsao, Anne S., Timothy J. McDonnell, Stephen Lam, et al.. (2003). Increased Phospho-AKT (Ser473) Expression in Bronchial Dysplasia. Cancer Epidemiology and Prevention Biomarkers. 12(7). 660–664. 2 indexed citations
20.
Tseng, Jennifer, B L Kemp, Fadlo R. Khuri, et al.. (1999). Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers.. PubMed. 59(19). 4798–803. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Domenico Delia Breakdown of academic impact, for papers by Lu‐Zhe Sun Breakdown of academic impact, for papers by Daniel Medina Breakdown of academic impact, for papers by Johan Botling Breakdown of academic impact, for papers by Elvira Pelosi Breakdown of academic impact, for papers by Pedram Argani Breakdown of academic impact, for papers by Chuan‐Yuan Li Breakdown of academic impact, for papers by Maréne Landström Breakdown of academic impact, for papers by Félix Bonilla Breakdown of academic impact, for papers by Giulia Taraboletti
Rankless by CCL
2026